Clinical Trials Browser

OTHER × Colorectal Neoplasms × penpulimab × Clear all

NCT06853769 2025-03-03

LARC-nCR01

Phase EARLY_PHASE1 Active not recruiting

Gastrointestinal

Colorectal Neoplasms

NCT05229003 2024-07-03

Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRC

Phase 2 Recruiting

Gastrointestinal

Colorectal Neoplasms

NCT04970914 2022-03-08

ALTER-C003

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms